Georgina Long
MBBS, PhD
Co-Medical Director of Melanoma Institute Australia
👥Biography 个人简介
Georgina Long has been a central investigator in nearly every pivotal adjuvant and neoadjuvant melanoma trial including CheckMate-238, COMBI-AD, and NADINA, shaping global treatment of resected high-risk melanoma. As co-director of Melanoma Institute Australia she drives translational biomarker research. She integrates targeted and IO approaches across perioperative settings.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Georgina Long 的研究动态
Follow Georgina Long's research updates
留下邮箱，当我们发布与 Georgina Long（Melanoma Institute Australia and University of Sydney）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment